☰

Robert D. Daber, Ph.D. - Publications

Affiliations: 
2009 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Biochemistry, Molecular Biology, Medical Biophysics
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Glodzik D, Selenica P, Rogge RA, Silverman IM, Mandelker D, Harris S, Zhao J, Zinda M, Veloso A, Malani N, Riaz N, Koehler M, Daber RD, Johnson V, Rimkunas V, et al. Detection of biallelic loss of DNA repair genes in formalin-fixed, paraffin-embedded tumor samples using a novel tumor-only sequencing panel. The Journal of Molecular Diagnostics : Jmd. PMID 36944408 DOI: 10.1016/j.jmoldx.2023.02.004  0.316
2018 Sussman RT, Shaffer S, Azzato EM, DeSloover D, Farooqi MS, Meyer A, Lieberman DB, Bigdeli A, Paolillo C, Ganapathy K, Sukhadia S, Rosenbaum JN, Daber RD, Morrissette JJD. Validation of a next-generation sequencing oncology panel optimized for low input DNA. Cancer Genetics. 228: 55-63. PMID 30553474 DOI: 10.1016/J.Cancergen.2018.08.004  0.375
2018 Strickland SA, Shaver AC, Byrne M, Daber RD, Ferrell PB, Head DR, Mohan SR, Mosse CA, Moyo TK, Stricker TP, Vnencak-Jones C, Savona MR, Seegmiller AC. Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia. Leukemia Research. 65: 67-73. PMID 29310020 DOI: 10.1016/J.Leukres.2017.12.012  0.322
2017 Maxwell KN, Wubbenhorst B, Wenz BM, De Sloover D, Pluta J, Emery L, Barrett A, Kraya AA, Anastopoulos IN, Yu S, Jiang Y, Chen H, Zhang NR, Hackman N, D'Andrea K, ... Daber R, et al. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers. Nature Communications. 8: 319. PMID 28831036 DOI: 10.1038/S41467-017-00388-9  0.369
2016 Yee SS, Lieberman DB, Blanchard T, Rader J, Zhao J, Troxel AB, DeSloover D, Fox AJ, Daber RD, Kakrecha B, Sukhadia S, Belka GK, DeMichele AM, Chodosh LA, Morrissette JJ, et al. A novel approach for next-generation sequencing of circulating tumor cells. Molecular Genetics & Genomic Medicine. 4: 395-406. PMID 27468416 DOI: 10.1002/Mgg3.210  0.361
2016 Sloan CE, Luskin MR, Boccuti AM, Sehgal AR, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Gimotty PA, Carroll M. A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia. Plos One. 11: e0153016. PMID 27050425 DOI: 10.1371/Journal.Pone.0153016  0.343
2016 Hiemenz MC, Kadauke S, Lieberman DB, Roth DB, Zhao J, Watt CD, Daber RD, Morrissette JJ. Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing. Plos One. 11: e0152851. PMID 27043212 DOI: 10.1371/Journal.Pone.0152851  0.407
2015 Sehgal AR, Gimotty PA, Zhao J, Hsu JM, Daber R, Morrissette JD, Luger S, Loren AW, Carroll M. DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1614-20. PMID 25609058 DOI: 10.1158/1078-0432.Ccr-14-0327  0.381
2015 Fishbein L, Khare S, Wubbenhorst B, DeSloover D, D'Andrea K, Merrill S, Cho NW, Greenberg RA, Else T, Montone K, LiVolsi V, Fraker D, Daber R, Cohen DL, Nathanson KL. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nature Communications. 6: 6140. PMID 25608029 DOI: 10.1038/Ncomms7140  0.422
2015 Shaver AC, Seegmiller AC, Strickland SA, Daber RD, Mohan SR, Ferrell PB, Vnencak-Jones C, Head DR, Kim AS, Zutter MM, Savona MR. Mutational Burden in Acute Myeloid Leukemia Is Largely Age Dependent Blood. 126: 2605-2605. DOI: 10.1182/Blood.V126.23.2605.2605  0.388
2015 Zhao J, Sukhadia S, Fox A, Lieberman D, Li B, Daber RD, Hiemenz MC, Roth DB, Martinez-Large M, Desai A, O'Rourke DM, Maus MV, Morrissette JJ. Abstract 4916: Development of a NGS-based method for EGFRvIII detection: sequence analysis of the junction Cancer Research. 75: 4916-4916. DOI: 10.1158/1538-7445.Am2015-4916  0.37
2015 Ahmed S, Aggarwal C, Mick R, Bauml J, Cohen R, Kadauke S, Sterlicchi T, Evans TL, Kucharczuk JC, Desphande C, Morrissette JJD, Daber R, Langer CJ. Abstract 4333: Association of TP53 mutation status with clinical outcomes in patients with EGFR mutated non-small cell lung cancer (NSCLC) Cancer Research. 75: 4333-4333. DOI: 10.1158/1538-7445.Am2015-4333  0.359
2015 Maxwell KN, Sloover DD, Wubbenhorst B, Wenz B, Lunceford N, Emery L, D'Andrea K, Daber RD, Feldman MD, Domchek SM, Nathanson KL. Abstract 2990: Evidence for diverse mechanisms of tumorigenesis in breast and ovarian tumors of BRCA1/2 carriers Cancer Research. 75: 2990-2990. DOI: 10.1158/1538-7445.Am2015-2990  0.404
2014 Wilson MA, Morrissette JJ, McGettigan S, Roth D, Elder D, Schuchter LM, Daber RD. What you are missing could matter: a rare, complex BRAF mutation affecting codons 599, 600, and 601 uncovered by next generation sequencing. Cancer Genetics. 207: 272-5. PMID 25178945 DOI: 10.1016/J.Cancergen.2014.06.022  0.426
2014 Oshrine BR, Olsen MN, Heneghan M, Wertheim G, Daber R, Wilmoth DM, Biegel JA, Pawel B, Aplenc R, King RL. Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor. Cancer Genetics. 207: 153-9. PMID 24831771 DOI: 10.1016/J.Cancergen.2014.03.009  0.414
2014 Meng W, Jayaraman S, Zhang B, Schwartz GW, Daber RD, Hershberg U, Garfall AL, Carlson CS, Luning Prak ET. Trials and Tribulations with VH Replacement. Frontiers in Immunology. 5: 10. PMID 24523721 DOI: 10.3389/Fimmu.2014.00010  0.301
2014 Daber RD, Langer CJ, Luger SM, Schuchter LM, Gilliland DG, Roth D, Carroll M, Nathanson KL, Morrissette JJ. A look back: Results from 1 year of routine clinical testing of both hematologic and solid tumors using two targeted next-generation sequencing (NGS) panels. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E22099  0.432
2014 Morrissette JJ, Zhao J, Bagg A, Frank D, Luger SM, Carroll M, Daber RD. A next-generation sequencing approach to capturing CEBPA: A hematologic malignancy sequencing panel capturing clinically useful targets. Journal of Clinical Oncology. 32: 7096-7096. DOI: 10.1200/Jco.2014.32.15_Suppl.7096  0.418
2014 Sloan CE, Gimotty PA, Boccuti AM, Sehgal A, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Carroll M. Predicting prognosis in patients with acute myeloid leukemia: The role of next-generation sequencing and mutational profiling. Journal of Clinical Oncology. 32: 7068-7068. DOI: 10.1200/Jco.2014.32.15_Suppl.7068  0.404
2014 Luskin MR, Carroll M, Morrissette JJ, Daber RD, Frey NV, Loren AW, Hexner EO, Mangan JK, Perl AE, Sloan CE, Stadtmauer EA, Bagg A, Luger SM, Porter DL, Reshef R. Next-generation sequencing to identify mutations that may predict outcome after allogeneic stem cell transplantation for AML. Journal of Clinical Oncology. 32: 7043-7043. DOI: 10.1200/Jco.2014.32.15_Suppl.7043  0.395
2014 Carlson CS, Garfall AL, Meng W, Daber R, Zhang B, Hershberg U, Cohen AD, Vogl DT, Brendan W, Carroll M, Stadtmauer EA, Prak EL. Detection of the Malignant B Cell Clone in Multiple Myeloma Via High Throughput Sequencing Is Robust to Significant Levels of Somatic Hypermutation Blood. 124: 3413-3413. DOI: 10.1182/Blood.V124.21.3413.3413  0.355
2014 Sloan CE, Gimotty PA, Boccuti A, Sehgal AR, Zhao J, Daber R, Morrissette JJ, Luger SM, Bagg A, Carroll MP. Next Generation Mutational Profiling Improves Prognostication in Younger Patients with Acute Myeloid Leukemia Blood. 124: 1032-1032. DOI: 10.1182/Blood.V124.21.1032.1032  0.377
2014 Nasrallah MP, Martinez-Lage M, Fox A, Sukhadia S, Desai A, O'Rourke DM, Brem S, Roth D, Morrissette JJD, Daber RD. Abstract 3428: Validation and utilization of next generation sequencing in the clinical assessment of gliomas Cancer Research. 74: 3428-3428. DOI: 10.1158/1538-7445.Am2014-3428  0.447
2014 Garfall AL, Prak ETL, Meng W, Daber R, Zhang B, Hershberg U, Vogl DT, Weiss BM, Carroll M, Stadtmauer EA, Carlson C. High-Throughput Sequencing of Antibody Genes Successfully Identifies Clonal Ig Rearrangements in Multiple Myeloma Patients Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.090  0.328
2013 Daber R, Sukhadia S, Morrissette JJD. Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets Cancer Genetics and Cytogenetics. 206: 441-448. PMID 24528889 DOI: 10.1016/J.Cancergen.2013.11.005  0.392
2013 Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJ, Daber R, Bagg A. BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia. Blood. 122: 3084-5. PMID 24159168 DOI: 10.1182/Blood-2013-07-513523  0.342
2013 Wertheim GB, Daber R, Bagg A. Molecular diagnostics of acute myeloid leukemia: it's a (next) generational thing. The Journal of Molecular Diagnostics : Jmd. 15: 27-30. PMID 23159532 DOI: 10.1016/J.Jmoldx.2012.08.002  0.346
2013 Maxwell KN, De Sloover D, Emery L, Wubbenhorst B, D'Andrea KP, Long J, Mueller R, Powers J, Stopfer J, Feldman MD, Domchek SM, Daber R, Nathanson KL. The mutational spectrum of breast and ovarian tumors from BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology. 31: 1510-1510. DOI: 10.1200/Jco.2013.31.15_Suppl.1510  0.401
2011 Zhang L, Znoyko I, Costa LJ, Conlin LK, Daber RD, Self SE, Wolff DJ. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genetics. 204: 654-65. PMID 22285017 DOI: 10.1016/J.Cancergen.2011.10.012  0.324
2011 Daber R, Sochor MA, Lewis M. Thermodynamic analysis of mutant lac repressors. Journal of Molecular Biology. 409: 76-87. PMID 21459098 DOI: 10.1016/J.Jmb.2011.03.057  0.334
Show low-probability matches.